New data from Eli Lilly and Company showed Omvoh-treated patients with moderately to severely active ulcerative colitis (UC) and bowel urgency experienced early improvements in bowel urgency severity, ...

Co-Diagnostics, Inc.  (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced that it has ...

The Ministry of Health and Prevention (MoHAP), in collaboration with its strategic partners from the health sector, has launched the updated scientific guidelines for the National Tuberculosis Control ...

GlaxoSmithKline (GSK) has recently completed a Phase 2A clinical study titled A Parallel Group, Phase 2A, Randomised, Open Label Treatment Study to Assess the Early Bactericidal Activity, Safety and ...